Myriad Genetics
MYGN
#6668
Rank
$0.67 B
Marketcap
$7.28
Share price
2.90%
Change (1 day)
-51.11%
Change (1 year)

Myriad Genetics (MYGN) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $0.35 Billion USD

According to Myriad Genetics's latest financial reports the company's total liabilities are $0.35 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Myriad Genetics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$0.32 B-10.13%
2023-12-31$0.36 B16.11%
2022-12-31$0.31 B-11.33%
2021-12-31$0.35 B
2020-06-30$0.48 B2.66%
2019-06-30$0.47 B126.48%
2018-06-30$0.20 B-52.55%
2017-06-30$0.44 B233.01%
2016-06-30$0.13 B27.19%
2015-06-30$0.10 B-0.67%
2014-06-30$0.10 B39.31%
2013-06-30$75.22 M36.84%
2012-06-30$54.97 M24.84%
2011-06-30$44.03 M21.42%
2010-06-30$36.26 M12.74%
2009-06-30$32.16 M-56.34%
2008-06-30$73.68 M109.47%
2007-06-30$35.17 M31.15%
2006-06-30$26.82 M15.19%
2005-06-30$23.28 M54.41%
2004-06-30$15.08 M-22.01%
2003-06-30$19.33 M-32.2%
2002-06-30$28.52 M-12.47%
2001-06-30$32.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Bio-Rad Laboratories
BIO
$2.95 B 732.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Exact Sciences
EXAS
$3.39 B 856.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
$21.81 M-93.86%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$1.55 B 338.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$32.91 B 9,164.57%๐Ÿ‡บ๐Ÿ‡ธ USA